-
Innovation Ranking
NewInnovation Ranking – Axon Enterprise Inc
Axon Enterprise Inc (Axon) is a manufacturer of conducted electrical weapons. The company provides sensors hardware such as on body cameras, fleet in car video systems, and computer-aided dispatch software. It also provides evidence connected software network, software-as-a-service (SaaS) solutions and cloud-based records management system. It markets products under TASER and Axon brand names. Axon market its products and services to law enforcement, military, corrections, private security, healthcare security and individual clients. The company sells and distributes its products through...
-
Innovation Ranking
NewInnovation Ranking – Axonics Modulation Technologies Inc
Axonics Inc (Axonics) is a medical technology company that focuses on the design, development and commercialization of novel products for adults with bladder and bowel dysfunction. The company offers rechargeable and recharge-free sacral neuromodulation systems (SNM) including Axonics F15 and R20 systems for treating overactive bladder, fecal incontinence and urinary retention. It also offers Bulkamid, a urethral bulking agent for female stress urinary incontinence. The company has operations in Canada, Australia, the US and other regions in Europe. Axonics is...
-
Thematic Analysis
NewMedical Devices M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Medical Devices Sector
-
Product Insights
NewLikelihood of Approval Analysis for Relapsing Multiple Sclerosis (RMS)
Overview How likely is it that the drugs in Relapsing Multiple Sclerosis (RMS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Relapsing Multiple Sclerosis (RMS) Overview Multiple sclerosis (MS) is the...
-
Thematic Analysis
NewGlobal M&A Deals in Q1 2024 – Top Themes by Sector – Thematic intelligence
The global M&A market in Q1 2024 witnessed deals worth $613 billion, a rise of 38% compared to Q1 2024. In terms of deal volume, there was a 13% fall from 8,468 deals in Q1 2023 to 7,248 M&A deals in Q1 2024. The TMT sector led the M&A deal activity, with 2,163 deals worth $186 billion recorded in Q1 2024. Most sectors saw a year-on-year increase in deal activity in Q1 2024. Mega-deals (defined as any deal valued at...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Iluzanebart in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Iluzanebart in Neurodegenerative Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Iluzanebart in Neurodegenerative Diseases Drug Details: VGL-101 is under development for the...
-
Company Insights
Innovation and Patenting activity of Axonics Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Axonics Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Insights
Innovation and Patenting activity of Axon Enterprise Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Axon Enterprise Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewCardiac Ablation Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Ablation Devices Pipeline Market Report Overview Cardiac ablation devices use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The cardiac ablation devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
NewTotal Artificial Heart Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart. GlobalData's Medical Devices sector report, “Total Artificial Heart Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Total Artificial Heart pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Total Artificial Heart report...